Ardelyx Stock In The News

ARDX Stock  USD 5.47  0.05  0.92%   
Our overall analysis of Ardelyx's news coverage and content from conventional and social sources shows investors' bearish mood towards Ardelyx. The specific impact of Ardelyx news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ardelyx's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ardelyx headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ardelyx Backtesting and Ardelyx Hype Analysis.
For more information on how to buy Ardelyx Stock please use our How to Invest in Ardelyx guide.

Ardelyx Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
https://www.globenewswire.com/news-release/2025/03/13/3042162/0/en/Ardelyx-Announces-the-First-Recipients-of-Derek-Forfang-Patient-Advocate-Award.html
 Bullish
Yahoo News
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
https://finance.yahoo.com/news/ardelyx-announces-first-recipients-derek-120200199.html
 Bullish
Yahoo News
High Growth Tech Stocks In The US With Promising Potential
https://finance.yahoo.com/news/high-growth-tech-stocks-us-170814645.html
 Bullish
Yahoo News
Ardelyx Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
https://finance.yahoo.com/news/ardelyx-full-2024-earnings-revenues-191053442.html
 Neutral
Yahoo News
Ardelyx Says China Approves New Drug Application for Hyperphosphatemia Treatment Tenapanor; Shares Up Pre-Bell
https://finance.yahoo.com/news/ardelyx-says-china-approves-drug-142622508.html
 Neutral
Macroaxis News: globenewswire.com
Tenapanor Approved in China for Hyperphosphatemia
https://www.globenewswire.com/news-release/2025/02/26/3032784/0/en/Tenapanor-Approved-in-China-for-Hyperphosphatemia.html
 Bullish
Yahoo News
Tenapanor Approved in China for Hyperphosphatemia
https://finance.yahoo.com/news/tenapanor-approved-china-hyperphosphatemia-120000181.html
 Bullish
Macroaxis News: globenewswire.com
Ardelyx to Participate in Upcoming Investor Conferences
https://www.globenewswire.com/news-release/2025/02/25/3032455/0/en/Ardelyx-to-Participate-in-Upcoming-Investor-Conferences.html
 Bullish
Yahoo News
Ardelyx to Participate in Upcoming Investor Conferences
https://finance.yahoo.com/news/ardelyx-participate-upcoming-investor-conferences-211500031.html
 Bullish
Investors Business Daily at Macroaxis
Institutional investors may adopt severe steps after Ardelyx, Inc.'s (NASDAQ:ARDX) latest 11% drop adds to a year losses
https://finance.yahoo.com/news/institutional-investors-may-adopt-severe-185138757.html
 Bullish

Ardelyx Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ardelyx and other traded companies coverage with news coverage. We help investors stay connected with Ardelyx headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Ardelyx Stock performance. Please note that trading solely based on the Ardelyx hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ardelyx's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Ardelyx investors visualize upcoming and past events in order to time the market based on Ardelyx noise-free hype analysis.
Ardelyx stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ardelyx earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ardelyx that are available to investors today. That information is available publicly through Ardelyx media outlets and privately through word of mouth or via Ardelyx internal channels. However, regardless of the origin, that massive amount of Ardelyx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ardelyx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ardelyx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ardelyx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ardelyx alpha.

Ardelyx Largest EPS Surprises

Earnings surprises can significantly impact Ardelyx's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-20
2024-12-31-0.00070.020.02072957 
2024-02-22
2023-12-31-0.09-0.12-0.0333 
2023-08-02
2023-06-30-0.11-0.080.0327 
2023-05-03
2023-03-31-0.1-0.13-0.0330 
2022-11-03
2022-09-30-0.17-0.140.0317 
2024-08-01
2024-06-30-0.11-0.070.0436 
View All Earnings Estimates

Ardelyx Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ardelyx Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
13th of March 2025
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
at gurufocus.com 
news
5th of March 2025
Cantor Fitzgerald Upgrades Ardelyx to Strong-Buy
at thelincolnianonline.com 
news
27th of February 2025
Ardelyx, Inc. Director David M. Mott Buys 77,729 Shares of Stock
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
26th of February 2025
Tenapanor Approved in China for Hyperphosphatemia
at gurufocus.com 
Gurufocus Stories at Macroaxis
25th of February 2025
Ardelyx to Participate in Upcoming Investor Conferences
at gurufocus.com 
Gurufocus Stories at Macroaxis
21st of February 2025
Q4 2024 Ardelyx Inc Earnings Call Transcript
at gurufocus.com 
Yahoo News
20th of February 2025
Ardelyx Reports Q4 Earnings What Key Metrics Have to Say
at finance.yahoo.com 
news
28th of January 2025
Piper Sandler Increases Ardelyx Price Target to 8.00
at kalkinemedia.com 
Gurufocus Stories at Macroaxis
6th of January 2025
Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
at gurufocus.com 

Ardelyx Investors Sentiment

The influence of Ardelyx's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ardelyx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ardelyx's public news can be used to forecast risks associated with an investment in Ardelyx. The trend in average sentiment can be used to explain how an investor holding Ardelyx can time the market purely based on public headlines and social activities around Ardelyx. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ardelyx's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ardelyx's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ardelyx's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ardelyx.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ardelyx in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ardelyx's short interest history, or implied volatility extrapolated from Ardelyx options trading.

Additional Tools for Ardelyx Stock Analysis

When running Ardelyx's price analysis, check to measure Ardelyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ardelyx is operating at the current time. Most of Ardelyx's value examination focuses on studying past and present price action to predict the probability of Ardelyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ardelyx's price. Additionally, you may evaluate how the addition of Ardelyx to your portfolios can decrease your overall portfolio volatility.